(GMAB) – Analyst Ratings
-
Genmab A/S (GEN:DC) (GMAB) PT Raised to DKK1,860 at Citi
-
BMO Capital Upgrades Genmab A/S (GMAB) to Outperform 'On Improved Outlook ex-Darzalex, Pipeline Optionality'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to GMAB Stock Lookup